View Item 

Show simple item record

The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease
dc.contributor.authorRao, H.
dc.contributor.authorWu, E.
dc.contributor.authorFu, S.
dc.contributor.authorYang, M.
dc.contributor.authorFeng, B.
dc.contributor.authorLin, A.
dc.contributor.authorFei, R.
dc.contributor.authorFontana, R. J.
dc.contributor.authorLok, A. S.
dc.contributor.authorWei, L.
dc.date.accessioned2017-10-05T18:16:30Z
dc.date.available2019-01-07T18:34:35Zen
dc.date.issued2017-10
dc.identifier.citationRao, H.; Wu, E.; Fu, S.; Yang, M.; Feng, B.; Lin, A.; Fei, R.; Fontana, R. J.; Lok, A. S.; Wei, L. (2017). "The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease." Alimentary Pharmacology & Therapeutics (8): 731-740.
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.urihttps://hdl.handle.net/2027.42/138216
dc.publisherWiley Periodicals, Inc.
dc.publisherPeking University Medical Press
dc.titleThe higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138216/1/apt14273.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138216/2/apt14273_am.pdf
dc.identifier.doi10.1111/apt.14273
dc.identifier.sourceAlimentary Pharmacology & Therapeutics
dc.identifier.citedreferenceGao X, Cui Q, Shi X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta‐analysis. BMC Infect Dis. 2011; 11: 88.
dc.identifier.citedreferenceDe Martel C, Maucort‐Boulch D, Plummer M, Franceschi S. World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015; 62: 1190 ‐ 1200.
dc.identifier.citedreferenceOtt JJ, Stevens GA, Groeger J, et al. Global epidemiology of hepatitis B virus infection: new estimates of age‐specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30: 2212 ‐ 2219.
dc.identifier.citedreferenceSeeff LB. The history of the “natural history” of hepatitis C (1968‐2009). Liver Int. 2009; 29: S89 ‐ S99.
dc.identifier.citedreferenceLok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C‐related advanced liver disease. Gastroenterology. 2009; 136: 138 ‐ 148.
dc.identifier.citedreferenceRao HY, Sun DG, Yang RF, et al. Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12‐19 year cohort study. J Gastroenterol Hepatol. 2012; 27: 526 ‐ 532.
dc.identifier.citedreferenceWestbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014; 61: S58 ‐ S68.
dc.identifier.citedreferenceLingala S, Ghany MG. Natural history of hepatitis C. Gastroenterol Clin North Am. 2015; 44: 717 ‐ 734.
dc.identifier.citedreferenceBravi F, Bosetti C, Tavani A, et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta‐analysis. Clin Gastroenterol Hepatol. 2013; 11: 1413 ‐ 1421.
dc.identifier.citedreferenceLai GY, Weinstein SJ, Albanes D, et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer. 2013; 109: 1344 ‐ 1351.
dc.identifier.citedreferenceBruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020 ‐ 1022.
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes‐2014. Diabetes Care. 2014; 37: S14 ‐ S80.
dc.identifier.citedreferenceChinese Diabetes Society. China guideline for type 2 diabetes‐2010. Beijing: Peking University Medical Press; 2011: 6.
dc.identifier.citedreferenceDu T, Sun X, Yin P, et al. Increasing trends in central obesity among Chinese adults with normal body mass index, 1993‐2009. BMC Public Health. 2013; 13: 327.
dc.identifier.citedreferenceFlegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999‐2010. JAMA. 2012; 307: 491 ‐ 497.
dc.identifier.citedreferenceWang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology. 2014; 60: 2099 ‐ 2108.
dc.identifier.citedreferenceWhite DL, Tavakoli‐Tabasi S, Kuzniarek J, et al. Higher serum testosterone is associated with increased risk of advanced hepatitis C‐related liver disease in males. Hepatology. 2012; 55: 759 ‐ 768.
dc.identifier.citedreferenceCarreño V. Review article: management of chronic hepatitis C in patients with contraindications to anti‐viral therapy. Aliment Pharmacol Ther. 2014; 39: 148 ‐ 162.
dc.identifier.citedreferenceArnold M, Leitzmann M, Freisling H, et al. Obesity and cancer: an update of the global impact. Cancer Epidemiol. 2016; 41: 8 ‐ 15.
dc.identifier.citedreferenceDyal HK, Aguilar M, Bartos G, et al. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review. Dig Dis Sci. 2016; 61: 636 ‐ 645.
dc.identifier.citedreferenceHuang YW, Wang TC, Yang SS, et al. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study. Aliment Pharmacol Ther. 2015; 42: 902 ‐ 911.
dc.identifier.citedreferenceDyal HK, Aguilar M, Bhuket T, et al. Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review. Dig Dis Sci. 2015; 60: 2813 ‐ 2824.
dc.identifier.citedreferenceGoossens N, Negro F. The impact of obesity and metabolic syndrome on chronic hepatitis C. Clin Liver Dis. 2014; 18: 147 ‐ 156.
dc.identifier.citedreferenceMarcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5‐year open‐label follow‐up study. Lancet. 2013; 381: 468 ‐ 475.
dc.identifier.citedreferenceLozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380: 2095 ‐ 2128.
dc.identifier.citedreferenceMohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013; 57: 1333 ‐ 1342.
dc.identifier.citedreferenceSievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31: 61 ‐ 80.
dc.identifier.citedreferenceDuan Z, Jia JD, Hou J, et al. Current challenges and the management of chronic hepatitis C in mainland China. J Clin Gastroenterol. 2014; 48: 679 ‐ 686.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt14273.pdf
Size:
526.0KB
Format:
PDF
View/Open
Name:
apt14273_am.pdf
Size:
293.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.